Meningeal Carcinomatosis — Trials

Meningeal Carcinomatosis — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 12
Ph III recruiting: 0
Growth YoY: —
Industry share: 7%
Top sponsor: Guangzhou Medical University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05305885	Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal Metastasis	unknown	N/A	100	The First Hospital of Jilin UniversityOTHER	1	Sep 30, 2022	clinicaltrials
NCT04944069	Almonertinib With Bevacizumab for EGFR-Mutant NSCLC Patients With Leptomeningeal Metastasis(ATTRACT)	unknown	N/A	69	Second Affiliated Hospital of Nanchang UniversityOTHER	1	Jun 29, 2021